
TSH levels are best understood as part of a thyroid feedback pattern, not as a diagnosis by themselves. Thyroid-stimulating hormone (TSH) is made by the pituitary gland and tells the thyroid how strongly to produce thyroid hormones. A high TSH result often appears when the thyroid is not producing enough hormone, while a low TSH result often appears when circulating thyroid hormone is high. Important exceptions include pregnancy, pituitary disease, acute illness, thyroid medication, other medicines, and laboratory interference. A TSH Test is therefore commonly paired with a T4 Free Test, and sometimes selected T3 or antibody testing, to clarify the pattern.
Medical note: This article is educational. It does not diagnose a thyroid disorder or provide an individualized treatment plan. Do not start, stop, double, delay, or change thyroid medication, another prescription medicine, or a supplement based on one result. Severe or rapidly worsening symptoms require prompt professional evaluation.
For a broader explanation of specimens, individual tests, panels, screening, and monitoring, see The Complete Guide to Lab Tests and Blood Work. To understand values, units, flags, reference intervals, clinical thresholds, and trends, use How to Read and Understand Your Lab Results. For test selection, ordering, preparation, collection, and follow-up, review Direct-Access Lab Testing: How It Works and What to Expect.
This focused guide complements the broader Thyroid Blood Tests: TSH, Free T4, Free T3, and Thyroid Antibodies pillar. Related health-category guides include Inflammation and Autoimmune Blood Tests, Women’s Hormone Blood Tests, and Fertility and Preconception Lab Tests.
| Test and quick facts | What it shows | Preparation, influences, and limits |
|---|---|---|
| TSH Test Use status: Common or first-line Specimen: Blood | Measures the pituitary signal that regulates thyroid hormone production. It is a sensitive starting test for many primary thyroid-function questions. | Fasting is often unnecessary. Pregnancy, age, acute illness, pituitary disease, medication, collection timing, biological variation, and assay interference can affect interpretation. |
| T4 Free Test Use status: Common, first-line follow-up, or monitoring Specimen: Blood | Measures unbound thyroxine and helps classify an abnormal TSH result. It is especially important when pituitary disease, pregnancy, or discordant results make TSH alone insufficient. | Thyroid medication timing, pregnancy, illness, binding changes, biotin, other medicines, and assay method may influence the result. |
| Free T3 Test Use status: Risk-based or targeted Specimen: Blood | Measures unbound triiodothyronine. It may add information in selected low-TSH or suspected hyperthyroid patterns. | It often adds little to routine evaluation for primary hypothyroidism. Free T3 methods vary, and illness or medicines can alter results. |
| Thyroid Peroxidase Antibodies Test Use status: Risk-based or targeted Specimen: Blood | Detects antibodies to thyroid peroxidase and can support an autoimmune cause, especially Hashimoto’s thyroiditis. | A positive result does not show current thyroid hormone output, explain every symptom, or establish a medication dose. |
| Thyroglobulin Antibodies Test Use status: Targeted or specialist-directed Specimen: Blood | Adds autoimmune context and is also important when thyroglobulin is being interpreted in thyroid-cancer follow-up. | It does not measure current thyroid function and should not be repeated automatically without a defined question. |
| TSI Test Use status: Targeted or specialist-directed Specimen: Blood | Measures thyroid-stimulating immunoglobulins that activate the TSH receptor and may support selected Graves’ disease questions. | It does not replace TSH and thyroid-hormone measurements, examination, or imaging when indicated. Pregnancy-related use requires professional guidance. |
| TSH and Free T4 Test Use status: Focused combined testing Specimen: Blood | Measures the central pituitary signal and circulating unbound T4 together when both results are needed. | The pair helps classify a pattern but does not by itself identify an autoimmune cause, characterize a nodule, or determine treatment. |
Thyroid-stimulating hormone—also called TSH or thyrotropin—is produced by the pituitary gland at the base of the brain. The pituitary responds to signals from the hypothalamus and to circulating thyroid hormones. It then adjusts how much TSH it releases. TSH binds to receptors on thyroid cells and stimulates the production and release of thyroxine (T4) and triiodothyronine (T3). Most hormone released by the thyroid is T4; tissues convert some T4 to the more active T3.
This relationship operates as a feedback loop. When circulating thyroid hormone falls, an intact pituitary usually increases TSH. When circulating thyroid hormone rises, the pituitary usually suppresses TSH. Because the relationship is sensitive and nonlinear, a relatively small change in Free T4 can be associated with a larger change in TSH. That makes TSH useful—but it also means a result must be interpreted with related hormones and the clinical setting.1

Fatigue, weight change, mood changes, hair loss, constipation, heat or cold intolerance, sleep changes, tremor, and palpitations can occur with thyroid dysfunction. They can also occur with anemia, iron deficiency, menopause, sleep disorders, medication effects, infection, heart rhythm disorders, diabetes, nutritional problems, anxiety, depression, and many other conditions. Laboratory testing adds objective information, but the results still require a history, medication review, examination, and sometimes imaging or other testing.
The safest way to interpret TSH is to combine its direction with Free T4 and, for selected low-TSH questions, T3. The table below is an educational framework—not a diagnostic or treatment algorithm. It assumes a generally stable adult with an intact pituitary-thyroid feedback system. Pregnancy, severe illness, pituitary disease, thyroid medication, and assay interference can change the pattern.
| Laboratory pattern | What the pattern may support | Why context and follow-up matter |
|---|---|---|
| High TSH + low Free T4 | Supports a primary hypothyroid pattern: the pituitary is signaling strongly, but circulating T4 is low. | Possible causes include Hashimoto’s thyroiditis, prior thyroid treatment, iodine imbalance, and medication effects. Symptoms, pregnancy status, severity, cause, and confirmation guide clinical decisions. |
| High TSH + Free T4 within the laboratory interval | Describes a subclinical hypothyroid biochemical pattern. | A mild elevation may be temporary. Persistence, degree of elevation, age, symptoms, antibodies, pregnancy, heart risk, and medications affect the next step. |
| Low TSH + high Free T4 and/or high T3 | Supports a primary hyperthyroid pattern. | Graves’ disease, thyroiditis, autonomous nodules, thyroid hormone exposure, iodine-containing medicines, and assay interference are among the possibilities. Antibodies or imaging may be needed to clarify the cause. |
| Low TSH + Free T4 and T3 within their laboratory intervals | Describes a subclinical hyperthyroid biochemical pattern. | Repeat confirmation and cause assessment are important. Age, heart rhythm, bone health, pregnancy, medicines, and how suppressed the TSH is can change clinical significance. |
| Low or inappropriately normal TSH + low Free T4 | Does not fit classic primary hypothyroidism. It can raise concern for central hypothyroidism involving the pituitary or hypothalamus. | Severe nonthyroidal illness, medication effects, and assay interference can create similar findings. Professional evaluation is important because TSH may appear normal or low despite inadequate thyroid hormone. |
| Normal TSH + persistent symptoms | With an intact feedback system, significant primary thyroid dysfunction is less likely. | A normal result does not explain the symptoms. Pituitary disease, pregnancy, acute illness, medications, and nonthyroid causes may require a different evaluation. |
| TSH and Free T4 move in an unexpected direction | May be a discordant pattern rather than straightforward hypo- or hyperthyroidism. | Review dose timing, supplements, medicines, illness, laboratory method, and prior results. Repeat testing, another assay method, or endocrine consultation may be appropriate. |

A high TSH result most often reflects increased pituitary signaling because thyroid hormone production is insufficient for the body’s current needs. The Free T4 result helps show whether the pattern is subclinical or overt. Common and important possibilities include:
For a deeper autoimmune interpretation, see Hashimoto’s Thyroiditis: Reading TSH, Free T4, TPO, and Thyroglobulin Antibodies as One Pattern.
A low TSH result often means the pituitary is reducing its signal because circulating thyroid hormone is high. Free T4 and selected T3 testing help distinguish overt from subclinical patterns. Possible causes include:
For a focused discussion of autoimmune hyperthyroidism, see Graves’ Disease: Symptoms, Causes, and Treatments.
Symptoms may create a reason to investigate, but they do not establish the cause. This framework connects common scenarios to focused questions.
| Symptom, risk factor, or scenario | Possible explanations | Focused testing and other evaluation |
|---|---|---|
| Fatigue, cold intolerance, constipation, dry skin, slowed thinking, heavier periods, or unexplained weight gain | Hypothyroidism is one possibility; anemia, iron deficiency, sleep disorders, depression, menopause, medicines, and metabolic conditions can overlap. | Consider a TSH and Free T4 Test when clinically appropriate. Persistent symptoms may require examination and targeted nonthyroid testing. |
| Heat intolerance, tremor, sweating, frequent bowel movements, anxiety, palpitations, or unexplained weight loss | Hyperthyroidism, arrhythmia, stimulant or medication effects, infection, anxiety, and other conditions can overlap. | TSH and Free T4 are central; a Free T3 Test may add information in selected low-TSH patterns. Heart rhythm assessment may be more urgent than routine testing. |
| Personal or family history of autoimmune thyroid disease, type 1 diabetes, celiac disease, or another autoimmune condition | Autoimmune thyroid disease may be more likely, but antibody positivity and current thyroid dysfunction are different questions. | Function testing comes first or is interpreted alongside targeted antibodies. The Thyroid Peroxidase Antibodies Test may support a Hashimoto-related question. |
| Known thyroid disease or a recent medication change | Values may reflect treatment response, adherence, absorption, dose timing, illness, weight change, or a change in the underlying condition. | Follow the prescribing clinician’s monitoring plan. TSH can lag after a dose or physiologic change; the appropriate marker and interval depend on the condition and medicine. |
| Pregnancy planning, fertility treatment, pregnancy, or postpartum symptoms | Pregnancy and postpartum physiology can change TSH, Free T4 interpretation, autoimmune activity, and medication requirements. | Use current pregnancy-specific guidance and prompt obstetric or endocrine review. Ordinary nonpregnant intervals and routine schedules may not apply. |
| Goiter, neck lump, hoarseness, pressure, swallowing difficulty, or neck asymmetry | Thyroid enlargement, nodules, inflammation, or nonthyroid neck conditions may be involved. | TSH may describe function, but examination and thyroid ultrasound evaluate structure. Blood tests cannot determine whether a nodule is benign or malignant. |
| Unexpected or discordant laboratory pattern | Preparation, biotin, medication timing, illness, assay interference, pituitary disease, or a less common thyroid disorder may be involved. | Review the complete context before repeating. Another assay method or endocrinology consultation may be needed. |
Urgent-care note: Chest pain, fainting, severe shortness of breath, new confusion, marked weakness, a very rapid or irregular heartbeat, very low body temperature, reduced responsiveness, or rapidly enlarging neck swelling with breathing or swallowing difficulty requires prompt professional or emergency evaluation. Routine outpatient testing should not delay care.
Educational framework—not a diagnostic or treatment algorithm.
Is the goal symptom evaluation, risk-based screening, confirmation of an earlier result, pregnancy-related assessment, medication monitoring, or clarification of an autoimmune cause? The purpose determines which markers add value.
For many stable, nonpregnant adults with a primary thyroid-function question, the TSH Test is a common starting point. Add the T4 Free Test when TSH is abnormal, pituitary disease is possible, pregnancy changes interpretation, or the clinical question requires both markers. NIDDK notes that an abnormal TSH generally requires at least one additional test to help clarify the problem.2
T3 testing is most useful for selected low-TSH or suspected hyperthyroid patterns, including situations in which T4 is not elevated but hyperthyroidism remains a concern. It is not automatically needed for suspected primary hypothyroidism, because T3 can remain within its reference interval even when TSH and Free T4 show hypothyroidism.2
Use antibody testing when identifying an autoimmune cause could change the evaluation or follow-up. TPO and thyroglobulin antibodies support Hashimoto-related questions. TSI supports selected Graves-related questions. Antibodies do not replace TSH and thyroid-hormone testing.
An isolated mild abnormality, a result collected during acute illness, or a pattern inconsistent with symptoms and prior testing may need repetition under more comparable conditions. Screening guidance from the U.S. Preventive Services Task Force emphasizes persistent abnormal TSH and follow-up T4 measurement rather than drawing a major conclusion from a single asymptomatic screening result.4
Antibody testing, ultrasound, electrocardiography, pituitary evaluation, or other symptom-directed testing may be more useful than adding every thyroid marker. The largest panel is not automatically the most informative.

TSH and Free T4 may be used to monitor an established condition or clinician-directed treatment. The relevant marker and interval depend on the diagnosis, medication, pregnancy status, pituitary function, recent dose change, symptoms, and prior results. TSH may take time to reflect a new steady state.
Pituitary testing, interference studies, receptor-antibody use during pregnancy, thyroid-cancer follow-up markers, and uncommon discordant patterns usually require specialist selection and interpretation.
| Option | When it may be useful | Advantages and limitations |
|---|---|---|
| TSH Test | A focused first measurement or a professionally defined monitoring plan when pituitary-thyroid feedback is expected to be reliable. | Focused and sensitive, but it does not directly measure circulating thyroid hormone or identify the cause of an abnormal result. |
| TSH and Free T4 Test | When both the pituitary signal and circulating unbound T4 are needed regardless of the first result. | Provides the central two-marker pattern. It does not identify every autoimmune cause, explain every symptom, or evaluate thyroid structure. |
| TSH, Free T4, and selected T3 testing | When a low-TSH or suspected hyperthyroid pattern requires additional hormone context. | May detect a T3-predominant pattern, but T3 testing is not automatically useful for routine hypothyroidism evaluation. |
| Function tests plus targeted antibodies | When the clinical question includes both current thyroid function and a suspected autoimmune cause. | Separates function from cause, but positive antibodies do not show current hormone output or automatically determine treatment. |
Preparation should follow the exact product instructions and the plan of the ordering or prescribing professional. Do not assume that one rule applies to every thyroid test, medicine, supplement dose, or laboratory method.
| Factor | How it may affect results | General guidance and caution |
|---|---|---|
| Fasting and food | Many thyroid tests do not require fasting, but food can matter when other tests are collected or when thyroid medication absorption is being evaluated. | Follow the instructions for the complete order. Do not fast longer than requested. |
| Time of day | TSH has a daily rhythm, and collection timing can contribute to small differences. | For trends, use reasonably comparable timing when practical and record major changes. |
| Thyroid medication dose timing | A recent dose, inconsistent use, missed doses, formulation changes, food, or interacting products can alter the pattern. | Follow the prescriber’s collection instructions. Never change or delay a prescription on your own. |
| Biotin | Biotin can interfere with some immunoassays and may produce falsely low TSH and falsely high thyroid-hormone results, although the direction depends on the assay. | Disclose the product, dose, and time last taken. Follow current test-specific and professional instructions; one pause interval does not fit every dose and method.6 |
| Prescription and nonprescription medicines | Amiodarone, lithium, glucocorticoids, dopamine-related medicines, estrogen, antiseizure medicines, immune therapies, and other drugs may change physiology, binding proteins, absorption, or assay interpretation. | Provide a complete list. Do not stop a medicine to prepare for testing unless the prescribing professional directs you. |
| Pregnancy and postpartum status | Pregnancy changes thyroid physiology, binding proteins, reference intervals, and monitoring needs. Postpartum autoimmune changes may shift results. | Use pregnancy-stage-specific professional guidance and prompt clinical review.5 |
| Acute or severe illness | Nonthyroidal illness can suppress TSH or alter T3 and T4 without a primary thyroid disorder. | Interpret results in the illness context. Urgent care takes priority over routine thyroid testing. |
| Laboratory method and interference | Different assays, binding abnormalities, heterophile antibodies, and other interference can produce discordant or misleading results. | Unexpected patterns may require repetition, another method, or laboratory and endocrine consultation. |

A laboratory reference interval describes values observed in a defined comparison population using a particular method. It is not automatically a diagnostic threshold, a treatment target, or a personal goal. TSH intervals can differ by laboratory and may also require age-, pregnancy-, population-, and method-specific context.
| Term | What it means | Patient caution |
|---|---|---|
| Reference interval | The range reported by the laboratory for a defined reference population and method. | A value outside the interval is not automatically disease; a value inside it does not explain every symptom. |
| Diagnostic or classification threshold | A criterion used in a defined clinical setting to classify a persistent biochemical pattern. | It may require repeat testing and may differ for pregnancy, age, illness, or treatment. |
| Treatment or monitoring target | A goal selected for a known condition and therapy. | It is individualized and may not equal the laboratory reference interval. |
Educational example only—this does not diagnose a patient.
A fictional adult receives a TSH result flagged above the reporting laboratory’s interval. The report does not include Free T4. Before concluding that the person has hypothyroidism, a responsible review would ask:
If a later Free T4 result is low, the combined pattern supports primary hypothyroidism. If Free T4 is within the laboratory interval, the pattern is classified differently and persistence matters. If Free T4 is unexpectedly high, the results are discordant and should prompt review of medication timing, interference, method, and less common conditions rather than an automatic diagnosis.
Repeat testing may be appropriate when a result is borderline, unexpected, inconsistent with symptoms, collected during acute illness, close to a decision threshold, or possibly affected by medication, supplements, timing, or assay interference. Persistence matters especially for subclinical patterns and asymptomatic screening findings.
After a clinician changes levothyroxine, TSH is commonly reassessed after enough time has passed for a new steady state—often about six to eight weeks in stable nonpregnant adults.3 Pregnancy, severe abnormalities, significant symptoms, medication type, pituitary disease, and other circumstances can require a different schedule. Stable long-term monitoring may be less frequent. The interval should answer a defined clinical question, not become automatic monthly testing.

There is no single screening schedule that applies to every adult. The U.S. Preventive Services Task Force concludes that evidence is insufficient to determine the balance of benefits and harms of screening nonpregnant adults who have no signs or symptoms of thyroid dysfunction. Risk-based case finding may still be appropriate when age, symptoms, pregnancy plans, thyroid history, autoimmune disease, family history, goiter, neck radiation, or relevant medication creates a reason to test.4
Monitoring a known thyroid condition is different from screening. People with established disease or thyroid medication should follow the plan defined by the treating professional.
| Testing may help show | Testing cannot establish by itself | What may be needed |
|---|---|---|
| Whether the pituitary signal and circulating hormone form a high-, low-, or discordant thyroid pattern. | Why every symptom is occurring or whether thyroid dysfunction is the only cause. | History, examination, medication review, and targeted evaluation for other causes. |
| Whether selected antibodies support an autoimmune cause. | Current thyroid function from antibody values alone. | TSH and thyroid-hormone results interpreted together. |
| Whether values are changing during a monitoring plan. | Whether a medication should be started, stopped, or changed without professional review. | The diagnosis, treatment history, symptoms, risks, and prescribing clinician’s plan. |
| Whether a thyroid gland is under- or overactive. | Whether a thyroid nodule is benign or malignant. | Neck examination, ultrasound, and sometimes fine-needle aspiration. |

Where available, eligible patients can review thyroid testing options online, see listed pricing before ordering, complete the applicable collection process, and receive results through an online account. A focused option may begin with an individual TSH Test or measure the core pair with a TSH and Free T4 Test.
Direct-access testing can provide objective information for a healthcare conversation, but it does not replace professional diagnosis, treatment, pregnancy care, medication management, imaging, or urgent evaluation. Review the current product instructions and the direct-access laboratory testing guide before ordering.
A TSH Test measures thyroid-stimulating hormone in blood. TSH is made by the pituitary gland and signals the thyroid to produce T4 and T3. It is a common first measurement for primary thyroid-function questions, but it does not directly measure thyroid hormone. An abnormal or unexpected result often requires Free T4 and clinical context.
There is no single universal TSH interval for every laboratory and patient. Use the reference information on the report and consider the assay, age, pregnancy status, illness, medications, and clinical purpose. A laboratory interval is not automatically a diagnostic threshold, treatment target, or individualized goal.
It often points toward reduced thyroid hormone production, but TSH alone does not establish the complete pattern. High TSH with low Free T4 supports primary hypothyroidism; high TSH with Free T4 within the laboratory interval describes a subclinical biochemical pattern. Temporary illness, medicines, biological variation, and interference can also matter.
No. Low TSH with high Free T4 and/or T3 supports a hyperthyroid pattern, but low TSH can also occur with thyroid medication exposure, pregnancy-related physiology, severe illness, medicines, thyroiditis, pituitary conditions, or assay interference. Free T4, selected T3 testing, history, and sometimes antibodies or imaging help clarify the cause.
Yes, in selected situations. Pituitary or hypothalamic disease can produce low Free T4 without the expected TSH rise. Pregnancy, acute illness, medicines, and assay interference can also make TSH less reliable. In a stable person with an intact feedback system, however, normal TSH makes significant primary thyroid dysfunction less likely.
TSH shows the pituitary signal, while Free T4 measures unbound circulating thyroxine. Reading them together distinguishes several common patterns, including overt versus subclinical primary hypothyroidism and overt versus subclinical hyperthyroidism. Free T4 is also important when pregnancy, pituitary disease, acute illness, or discordant symptoms make TSH alone insufficient.
No. A Free T3 Test may add information in selected low-TSH or suspected hyperthyroid patterns. It usually adds little to routine evaluation for primary hypothyroidism because T3 can remain within its interval despite high TSH and low Free T4. The measurement should answer a defined question rather than be added automatically.
Yes. Biotin can interfere with some immunoassays and may create a falsely low TSH result with falsely high thyroid-hormone measurements. The effect depends on dose, timing, and assay design. Tell the ordering professional and laboratory what you take and follow current test-specific instructions. Do not apply one universal pause rule to every product.
Many TSH tests do not require fasting, but preparation depends on the exact order and any other tests collected at the same time. Thyroid medication timing, supplements, acute illness, and collection time may matter for comparison. Follow the product and professional instructions rather than assuming every blood test uses the same preparation.
The interval depends on the degree and pattern of abnormality, symptoms, pregnancy status, illness, medication changes, and possible interference. Borderline asymptomatic results may be confirmed after an appropriate interval; treatment changes are often reassessed after enough time for a new steady state. Severe symptoms or pregnancy-related concerns require faster professional review.
Yes. TPO or thyroglobulin antibodies may be present while TSH and Free T4 remain within their laboratory intervals. That supports thyroid autoimmunity without proving current hypothyroidism. Antibody concentrations do not measure hormone output, and repeating them routinely is often less useful than monitoring thyroid function when clinically appropriate.
No. TSH helps assess thyroid function but cannot determine whether a nodule is benign or malignant. A lump, neck asymmetry, hoarseness, pressure, or swallowing difficulty warrants professional examination. Ultrasound evaluates nodule structure, and selected nodules may require fine-needle aspiration or other specialist evaluation.
Where available and appropriate, eligible patients may be able to review and order thyroid tests through Ulta Lab Tests. Direct-access results are informational. Abnormal, pregnancy-related, medication-related, severe, or discordant results should be reviewed with a qualified healthcare professional, and routine testing should never delay urgent care.
High and low TSH levels are signals within the pituitary-thyroid feedback system. A high result often appears when thyroid hormone production is insufficient; a low result often appears when circulating hormone is high. The actionable information comes from the pattern: TSH with Free T4, selected T3 testing, symptoms, medicines, pregnancy status, illness, prior trends, and possible assay interference.
Start with the smallest test set that answers the question, confirm unexpected results when appropriate, and use antibodies to investigate cause rather than current function. Ulta Lab Tests can support access to focused thyroid testing, but results should inform a professional conversation—not a self-diagnosis or medication change.
Commercial disclosure: Ulta Lab Tests offers laboratory-testing services and may link to tests or panels discussed on this page. This content is educational and does not provide individual diagnosis or treatment.
Update history: Originally published: August 29, 2024 | Substantively rewritten August 26, 2026 to distinguish high, low, subclinical, and discordant TSH patterns; clarify the roles of Free T4, selected T3 testing, and thyroid antibodies; add pregnancy, medication, illness, and assay-interference context; preserve the two existing educational images; and connect the page to current Ulta Lab Tests cornerstone and thyroid-pillar resources.
| Test | Use status | Purpose in the article |
|---|---|---|
| TSH Test | Common or first-line | Measures pituitary signaling to the thyroid |
| T4 Free Test | Common first-line follow-up or monitoring | Helps classify an abnormal or unreliable TSH pattern |
| TSH and Free T4 Test | Focused combined testing | Evaluates the central TSH–Free T4 relationship together |
| T3 Free Test | Risk-based or targeted | Adds information in selected low-TSH or suspected hyperthyroid patterns |
These antibody tests help investigate cause; they do not measure current thyroid function by themselves.
| Test | Use status | Purpose in the article |
|---|---|---|
| Thyroid Peroxidase Antibodies Test | Risk-based or targeted | Supports evaluation for autoimmune thyroid disease, especially Hashimoto’s thyroiditis |
| Thyroglobulin Antibodies Test | Targeted or specialist-directed | Adds autoimmune context in selected cases |
| TSI Test | Targeted or specialist-directed | Supports selected evaluation for Graves’ disease |

Ulta Lab Tests, LLC.
9237 E Via de Ventura, Suite 220
Scottsdale, AZ 85258
480-681-4081
(Toll Free: 800-714-0424)